GUILD Learning and Development partnered with MSD Australia to develop an online course titled 'Biosimilars in focus'.
This is the first of two CPD courses to be launched on this topic, with the second module focusing on MSD's Brenzys (etanercept), launching in Oct.
Pharmacists completing the course will be able to educate patients around the use of these medicines - myCPD.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Sep 17